FDA Exempts Eight More Device Classes From Premarket Notification Requirements

August 21, 2015

Last month FDA published a guidance (titled “Intent to Exempt Certain Unclassified, Class II, and Class I Reserved Medical Devices from Premarket Notification Requirements”) announcing that they would not be enforcing compliance with 510(k) requirements for certain classes of medical devices, and with that announcement they released a list of the 120 exempt classes (full list of exempt device classes here). This meant any devices falling into one of the 120 exempt classes would no longer have to comply with FDA’s premarket notification and review requirements, making it significantly easier to get device(s) on the market faster.

Last week, FDA updated this guidance adding eight additional classes that will no longer be required to comply with the Agency’s premarket notification and review requirements. The additional classes include the following:

Cardiovascular Devices:

  • DTL – Adaptor, Stopcock, Manifold, Fitting, Cardiopulmonary Bypass

Gastroenterology Devices:

  • OCY – Endoscopic Guidewire, Gastroenterology-urology
  • KOE – Dilator, Urethral

General & Plastic Surgical Devices:

  • FTA – Light, Surgical, Accessories

Neurological Devices:

  • GZM – Analyzer, Rigidity
  • GZO – Device, Galavanic Skin Response Measurement
  • HCJ – Device, Skin Potential Measurement

Ophthalmic Devices:

  • HLJ – Ophthalmoscope, Battery Powered

Not sure if your device falls into one of the exempt categories or not? We can help figure it out and achieve a successful outcome with FDA during the entire process of getting your medical device on the market. For more information on our services and how we can help you, please contact us.


September 2, 2016

FDA Extends Enforcement Deadline for Certain Provisions of the UDI Rule, Part Two

Additional information on FDA’s guidance document is available in our preceding FDA News article, entitled “FDA Extends Enforcement Deadline for Certain Provisions of the UDI Rule, Part One.” On...

September 19, 2018

FDA Considers Moving Medical Device Submissions to Electronic Format

On Thursday, September 13th, FDA published a proposed rule which would amend the current premarket submission requirements for medical devices. Background In July 2012, the Food and Drug...

March 22, 2016

FDA Finalizes the Establishment of the Patient Engagement Advisory Committee

In October 2015 the FDA established its first ever Patient Engagement Advisory Committee (PEAC). This was done as part of the Agency’s 'patient-centric' approach, under which FDA is attempting to...